Poly(lactic acid hydroxyacetic acid)-poly(ethylene glycol)-modified ginsenoside Rg3 nanomedicine enhances anti-tumor effect in hepatocellular carcinoma.

Saved in:
Bibliographic Details
Title: Poly(lactic acid hydroxyacetic acid)-poly(ethylene glycol)-modified ginsenoside Rg3 nanomedicine enhances anti-tumor effect in hepatocellular carcinoma.
Authors: Zheng W; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China., Huang Y; Institute of Translational Medicine, Zhejiang University, Hangzhou, China., Wu Q; Center for Modern Physics Technology, School of Mathematics and Physics, University of Science and Technology Beijing, Beijing, China., Cheng P; Department of Gynecology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China., Song Y; Center for Modern Physics Technology, School of Mathematics and Physics, University of Science and Technology Beijing, Beijing, China., Wang B; Institute of Translational Medicine, Zhejiang University, Hangzhou, China., Huang Q; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China., Hu S; Department of Obstetrics, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Key Laboratory of Pulsed Power Translational Medicine of Zhejiang Province, Hangzhou, China.
Source: Drug development and industrial pharmacy [Drug Dev Ind Pharm] 2024 Aug; Vol. 50 (8), pp. 763-775. Date of Electronic Publication: 2024 Sep 16.
Publication Type: Journal Article
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 7802620 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-5762 (Electronic) Linking ISSN: 03639045 NLM ISO Abbreviation: Drug Dev Ind Pharm Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1520-5762
DOI:10.1080/03639045.2024.2402769